The feds have busted 12 shady STD treatment companies—and the Better Business Bureau might be collateral damage
The Food and Drug Administration and the Federal Trade Commission joined forces Tuesday to threaten 12 companies with legal action over the manufacture and sale of products that purport to treat sexually transmitted diseases. The FDA's webpage alone, complete with the video STD Treatments That Don't Work, will prove a devastating assault to most of these businesses. Though it lacks the authority to carry out an IRS-style raid, the FDA has been using its legal department's fearsome prose to bust bad drugs sold as supplements for decades now, and in the past few years we've seen the agency ramp up these efforts as online commerce has driven the problem to epidemic proportions.
So while I expect a steady drumbeat of deadbeat drug bashing, I was instead far more interested to discover a prominent consumer rights nonprofit linked to the mess. The Better Business Bureau lent its considerable credibility to one of the companies the Feds are slamming for endangering the country's public health. What's more, the BBB followed its normal practices and policies in doing so, the organization told me yesterday.
The BBB's involvement became apparent once I decided to take a closer look at the assortment of crappy capsules the Feds are putting on notice. I zeroed in on Medavir, produced by a central-Florida based outfit called The Arenson Group (a.k.a. TAG Health). The internet is littered with TAG's websites selling Medavir under various names. While scrolling along you'll see the usual unsubstantiated claims and endorsements from unnamed physicians that one would expect from shady operators. "Over 90% of outbreaks do not occur when you apply Medavir at first signs of outbreak," one site says. Stop the presses! For your information, that compares to about an 50 to 60 percent chance of future genital herpes outbreaks while on FDA-approved medical treatment (versus a blistering 80 to 90 percent rate without treatment) according to a 2007 meta-analysis of available trial data.
The Arenson Group preys on ashamed kids and unsophisticated adults. Your sexual partner, your doctor, and the public health department need never know!
So how's the the BBB mixed up in this? Take a look at this screen shot from one of the Medavir sites:
As shown in the above screenshot, Medavir prominently displays its BBB Accredited Business logo in the upper left hand corner of its website. Unlike the sprinkling of other certifications and logos on the site that turn out to be illegitimate, BBB's is the real deal. Until earlier today when the organization heard from me and took down their rating, consumers could click on that link to see its A+ rating from the BBB:
The BBB accredited The Arenson Group in January 2009 "based on information provided by the company and our own research," says Holly Salmons, Vice President of BBB of Central Florida.
The bottom line? The BBB is pleased to accredit questionable pill purveyors when they market their mixtures as supplements. Because The Arenson Group's website included the statement "none of these statements have been fully evaluated by the FDA" at the time they applied for accreditation (it still does), the BBB was satisfied to welcome them into its brotherhood of legitimate American businesses. In fact, Ms. Salmons says that while as of Wednesday she has frozen Arenson's status in "update" mode, the BBB will suspend or restore their accreditation only pending their response to the FDA's demands.
Arenson could potentially satisfy federal regulators by removing all medical claims from its websites and packaging and marketing Medavir in some vague manner unconnected to treating herpes sufferers. That would leave little text on their sites indeed. I find it difficult to imagine what a website attempting to sell Medavir without claiming that it treats herpes would look like (what in the world is a "herpes supplement"?), and I'd love to see the original materials the BBB reviewed in 2009.
Once BBB approved Medavir's membership, the company wasn't slated for another review for three years, giving plenty of time for its claims to become progressively more egregious without any oversight. But lack of such frequent review doesn't seem to be the crux of the problem in my own analysis. BBB protests to me that Medavir's January 2009 materials fit classification as a supplement and did not overstep bounds into FDA-regulated territory. After reviewing versions of Medavir.com from January 2009 and the oldest available version from June 2008 over at the Internet Archive, I don't buy their version of events. Take a look back, and make your own call.
The Arenson Group showed off its A+ BBB rating to its vulnerable lot of prospective consumers as an implied seal of approval. This use, even for a health care product, is routine in BBB practice. "Accredited Businesses are permitted to report their rating as long as it is accurate at all times," BBB VP Salmons tells me. Arenson had just two complaints over three years, she says, which is a low complaint volume. Another BBB policy helps explain why Medavir might have so few complaints. BBB only accepts complaints that come with real names and documentation.
People searching out genital herpes cures from the privacy of their own homes are obviously reluctant or unable to do so in the care of actual medical professionals out there in the real world. These consumers must have found some reassurance in BBB's A+ rating, which is why the Medavir site advertised it high above the fold. Medavir had a perfectly marginalized population base from which to draw its A+ record: folks too anxiety-ridden to speak up once they realized they'd been scammed; STD sufferers who didn't think admitting they have herpes to a third party was worth it when that third party took the Hippocratic Oath certainly aren't going to confide their private secrets to the BBB.
The characters behind Medavir made BBB into a Bogus Balms Bureau. To get out of this fix, BBB needs to eject itself from the field of lending credibility to unregulated drug makers entirely. This means excluding health "supplements." It's hard enough for physicians and the FDA to weigh evidence about these agents. BBB ratings are bestowed by an organization with no possible claim to competence in mediating between patients and providers in the unique health care marketplace, as the policies that led to this case prove. Moreover, BBB ratings add nothing of value to any consumer considering what pills to take for an illness. Continuing to offer accreditation to firms like The Arenson Group (aka Medavir Medical Advances) of Windmere, Florida, whether or not they barely skirt FDA enforcement does a disservice to BBB's own heritage.
Even when a dentist kills an adored lion, and everyone is furious, there’s loftier righteousness to be had.
Now is the point in the story of Cecil the lion—amid non-stop news coverage and passionate social-media advocacy—when people get tired of hearing about Cecil the lion. Even if they hesitate to say it.
But Cecil fatigue is only going to get worse. On Friday morning, Zimbabwe’s environment minister, Oppah Muchinguri, called for the extradition of the man who killed him, the Minnesota dentist Walter Palmer. Muchinguri would like Palmer to be “held accountable for his illegal action”—paying a reported $50,000 to kill Cecil with an arrow after luring him away from protected land. And she’s far from alone in demanding accountability. This week, the Internet has served as a bastion of judgment and vigilante justice—just like usual, except that this was a perfect storm directed at a single person. It might be called an outrage singularity.
The Islamic State is no mere collection of psychopaths. It is a religious group with carefully considered beliefs, among them that it is a key agent of the coming apocalypse. Here’s what that means for its strategy—and for how to stop it.
What is the Islamic State?
Where did it come from, and what are its intentions? The simplicity of these questions can be deceiving, and few Western leaders seem to know the answers. In December, The New York Times published confidential comments by Major General Michael K. Nagata, the Special Operations commander for the United States in the Middle East, admitting that he had hardly begun figuring out the Islamic State’s appeal. “We have not defeated the idea,” he said. “We do not even understand the idea.” In the past year, President Obama has referred to the Islamic State, variously, as “not Islamic” and as al-Qaeda’s “jayvee team,” statements that reflected confusion about the group, and may have contributed to significant strategic errors.
The new version of Apple’s signature media software is a mess. What are people with large MP3 libraries to do?
When the developer Erik Kemp designed the first metadata system for MP3s in 1996, he provided only three options for attaching text to the music. Every audio file could be labeled with only an artist, song name, and album title.
Kemp’s system has since been augmented and improved upon, but never replaced. Which makes sense: Like the web itself, his schema was shipped, good enough,and an improvement on the vacuum which preceded it. Those three big tags, as they’re called, work well with pop and rock written between 1960 and 1995. This didn’t prevent rampant mislabeling in the early days of the web, though, as anyone who remembers Napster can tell you. His system stumbles even more, though, when it needs to capture hip hop’s tradition of guest MCs or jazz’s vibrant culture of studio musicianship.
A controversial treatment shows promise, especially for victims of trauma.
It’s straight out of a cartoon about hypnosis: A black-cloaked charlatan swings a pendulum in front of a patient, who dutifully watches and ping-pongs his eyes in turn. (This might be chased with the intonation, “You are getting sleeeeeepy...”)
Unlike most stereotypical images of mind alteration—“Psychiatric help, 5 cents” anyone?—this one is real. An obscure type of therapy known as EMDR, or Eye Movement Desensitization and Reprocessing, is gaining ground as a potential treatment for people who have experienced severe forms of trauma.
Here’s the idea: The person is told to focus on the troubling image or negative thought while simultaneously moving his or her eyes back and forth. To prompt this, the therapist might move his fingers from side to side, or he might use a tapping or waving of a wand. The patient is told to let her mind go blank and notice whatever sensations might come to mind. These steps are repeated throughout the session.
The authors in the running for Britain's most prestigious literary award come from seven countries and include seven women writers.
The longlist for the Man Booker Prize, one of the most prestigious literary awards, was announced Wednesday. For the second year, the prize was open to writers of any nationality who publish books in English in the U.K., and this year five American writers made the list of 13 contenders, chosen by five judges from a pool of 156 total works.
The U.S. is, in fact, the most well-represented country, with other entrants hailing from Great Britain, Jamaica, New Zealand, Nigeria, Ireland, and India. There are three debut novelists and one former winner on the list, and women writers outnumber men seven to six. From dystopian and political novels to a multitude of iterations on the family drama, the selections capture the ever-changing human experience in very different ways.
The Vermont senator’s revolutionary zeal has met its moment.
There’s no way this man could be president, right? Just look at him: rumpled and scowling, bald pate topped by an entropic nimbus of white hair. Just listen to him: ranting, in his gravelly Brooklyn accent, about socialism. Socialism!
And yet here we are: In the biggest surprise of the race for the Democratic presidential nomination, this thoroughly implausible man, Bernie Sanders, is a sensation.
He is drawing enormous crowds—11,000 in Phoenix, 8,000 in Dallas, 2,500 in Council Bluffs, Iowa—the largest turnout of any candidate from any party in the first-to-vote primary state. He has raised $15 million in mostly small donations, to Hillary Clinton’s $45 million—and unlike her, he did it without holding a single fundraiser. Shocking the political establishment, it is Sanders—not Martin O’Malley, the fresh-faced former two-term governor of Maryland; not Joe Biden, the sitting vice president—to whom discontented Democratic voters looking for an alternative to Clinton have turned.
For anyone who has ever caught some treacly adult contemporary on the radio and wondered “Who on earth likes this stuff?” while twisting the dial, a new study might have an answer. A bunch of softies, that’s who.
In the paper, published recently in the online journal PLoS One, Cambridge psychologist David Greenberg theorized that music tastes are determined in part by peoples’ tendency to fall into one of two rough personality categories: empathizers or systemizers. Empathizers are people who are very attuned to others’ emotions and mental states. Systemizers are more focused on patterns that govern the natural and physical worlds.
Over the course of multiple experiments that included 4,000 participants, listeners took personality questionnaires and then listened to and rated 50 pieces of music.
Forget credit hours—in a quest to cut costs, universities are simply asking students to prove their mastery of a subject.
MANCHESTER, Mich.—Had Daniella Kippnick followed in the footsteps of the hundreds of millions of students who have earned university degrees in the past millennium, she might be slumping in a lecture hall somewhere while a professor droned. But Kippnick has no course lectures. She has no courses to attend at all. No classroom, no college quad, no grades. Her university has no deadlines or tenure-track professors.
Instead, Kippnick makes her way through different subject matters on the way to a bachelor’s in accounting. When she feels she’s mastered a certain subject, she takes a test at home, where a proctor watches her from afar by monitoring her computer and watching her over a video feed. If she proves she’s competent—by getting the equivalent of a B—she passes and moves on to the next subject.
Members of Colombia's younger generation say they “will not torture for tradition.”
MEDELLÍN, Colombia—On a scorching Saturday in February, hundreds of young men and women in Medellín stripped down to their swimsuit bottoms, slathered themselves in black and red paint, and sprawled out on the hot cement in Los Deseos Park in the north of the city. From my vantage point on the roof of a nearby building, the crowd of seminude protesters formed the shape of a bleeding bull—a vivid statement against the centuries-old culture of bullfighting in Colombia.
It wasn’t long ago that Colombia was among the world’s most important countries for bullfighting, due to the quality of its bulls and its large number of matadors. In his 1989 book Colombia: Tierra de Toros (“Colombia: Land of Bulls”), Alberto Lopera chronicled the maturation of the sport that Spanish conquistadors had introduced to South America in the 16th century, from its days as an unorganized brouhaha of bulls and booze in colonial plazas to a more traditional Spanish-style spectacle whose fans filled bullfighting rings across the country.
An alpenhorn performance in Switzerland, a portrait of Vladimir Putin made of spent ammunition from Ukraine, Prince Charles surprised by an eagle, wildfire in California, a sunset in Crimea, and much more.
An alpenhorn performance in Switzerland, a portrait of Vladimir Putin made of spent ammunition from Ukraine, fireworks in North Korea, Prince Charles surprised by an eagle, wildfire in California, protests in the Philippines and Turkey, a sunset in Crimea, and much more.